Cesca Therapeutics loss widens, but cash up as push begins for FDA approval

March 29, 2018 - Less than a minute read

Cesca Therapeutics loss widens, but cash up as push begins for FDA approval

Sacramento Business Journal:  Cesca Therapeutics Inc. ended its fiscal year June 30 with increased losses but an infusion of cash to launch products into a new market